Introduction
The cause of the thrombocytopenia frequently encountered in Plasmodium falciparum malaria infection in man is poorly understood. The possible mechanisms suggested include consumption of platelets as part of disseminated intravascular coagulation (D.I.C.), a well described feature in severe cases of P. falciparum malaria (Devakul et al., 1966; Dennis et al., 1967; Borochovitz et al., 1970) , or excessive removal of normal or immunologically damaged platelets by a hypertrophied reticuloendothelial system (Hill et il., 1964; Sheagren et al., 1970; Shulman et al., 1970; Beale et al., 1972) .
Both mechanisms involve changes in platelet kinetics, as yet not reported in P. falciparum malaria.
In the present study platelet kinetic were measured in six patients with moderately severe P. falciparum malaria and thrombocytopenia. At the same time coagulation factors and plasma clearance of 12'I-labelled fibrinogen were measured. The results show excessive pooling of platelets associated with moderate shortening of platelet life span and increased platelet turnover. The rate of clearance from the plasma of injected "-II fibrinogen was moderately increased in all patients but changes in coagulation factors were minimal. These findings provide evidence that thrombocytopenia in uncomplicated cases of P. falciparum malaria is the result of SUBJECTS STUDIED Six white patients aged 
METHODS
Thrombokinetic studies with labelled platelets were carried out as described by Harker and Finch (1969) . Allogeneic platelets from ABO and Rh compatible donors were labelled with 5tCr and a measured volume was infused into the six patients. An aliquot of the infusion was retained for determination of the total platelet radioactivity injected. Blood samples were collected at one minute after the infusion of the platelets and a further four samples during the following hour, the fifth sample being drawn at exactly one hour after infusion. Subsequent samples were drawn at 24, 48, and 72 hours. Radioactivity of the platelet "buttons" prepared from the blood samples and from the suspension infused were determined in a well-type scintillation counter. Radioactivity from 12uI fibrinogen (see below) adsorbed on to the platelets was excluded by counting on a narrow window coinciding with the 51Cr peak. The platelet recovery was calculated from the platelet radioactivity extrapolated to zero time multiplied by the blood volume (estimated from height and weight) divided by the total platelet radioactivity injected. Platelet survival was estimated from disappearance curves by extrapolating to zero activity. In all six patients an exponential disappearance curve was obtained, and plate-00. (Harker and Finch, 1969) . In all six patients 100 uCi '25I-labelled fibrinogen (Radiochemical Centre, Amersham) was injected intravenously one hour after the platelet infusion and samples of venous blood drawn at 20 minutes and four hours, and then daily for three to five days. All patients were given either potassium iodide or Lugol's iodine to block the 1251 uptake by the thyroid gland. 125I radioactivity was measured in 10-ml samples of plasma. Contaminating 5tCr radioactivity released into the plasma from the labelled platelets was excluded by selection of appropriate counting conditions. The plasma radioactivity was plotted against time on semi-log paper, and the half life calculated according to Regoeczi (1971) . During the course of the malaria study aliquots of the same batches of 125I fibrinogen were injected into four other patients for the investigation of deep vein thrombosis. Two patients were receiving heparin treatment. O'Brien et al. (1972) reported that the rate of clearance of injected 1211 fibrinogen from the plasma of subjects with venous thrombosis is not significantly different from that of normal subjects.
Blood for coagulation studies was collected into 3-8% trisodium citrate in the proportion of 9:1. The samples were taken shortly before infusion of the 1251-labelled fibrinogen.
For the detection of fibrinogen-fibrin reacting antigen (F.R. antigen, previously termed F.D.P.) clotted blood was collected in tubes containing 1 ,ug Trasylol to prevent in-vitro fibrinolysis. Standard techniques for coagulation studies were used (Denson, 1966; Ellis and Stransky, 1961) and F.R. antigen was detected using Wellcome haemagglutination inhibition test kits.
Results

PLATELET KINETICS
In all six patients the pattern of platelet radioactivity after the infusion of 51Cr-labelled platelets was essentially similar (graph). After the initial rise there was a rapid fall in platelet radioactivity maximal at one hour. Platelet recovery in *the six patients was greatly reduced, ranging from 7 to 19% (mean 12-2%) (table II). In five healthy subjects studied with the identical technique platelet recovery ranged from 55 to 69% (mean 61-6%). After the rapid fall in the first hour after infusion platelet radioactivity decreased at a much slower rate during the subsequent 72 hours. Platelet life span calculated from this part of the curve was shortened in all patients, ranging from 2-0 to 3-7 days (mean 29) (table II) , compared with 7-10 days in normal subjects studied with the identical technique (Lurie et al., 1969) . Platelet turnover was increased in all patients, ranging from 96,000 to 345,000/,l/day (mean 147,000/,ul/day) (table II) . In normal subjects platelet turnover averaged 37,000/,ul/day (range 25,000-50,000).
1251-LABELLED FIBRINOGEN HALF LIFE AND COAGULATION TESTS
In the six malaria patients 1251 fibrinogen half life ranged from 22 to 48 hours (mean 35-5 hours) (table III). In the four control subjects the half life was 64, 67, 84, and 96 hours respectively (mean 77-8). Other than a slight increase in the concentration of F.R. antigen, the results of the coagulation tests in cases 1, 2, 3, 5, and 6 were within normal limits. In case 4 the plasma fibrinogen concentration (169 mg/100 ml) was slightly reduced and the factor VIII level (61%) was towards the lower limit of normal. The 1251 fibrinogen half life (33 hours) in this patient was not significantly different from the mean (35-5 hours) for the group of six patients. 
Discussion
The introduction of techniques to study platelet kinetics has enabled the mechanisms of thrombocytopenia in disease states to be better defined (Aas and Gardner, 1958) . After injection of labelled platelets into normal subjects the percentage of the platelets recovered varies inversely with the size of the splenic pool and is a reliable indication of its size. In the present study platelet recovery values after the injeotion of labelled platelets were greatly reduced, and in three subjects were less than 10%. These recoveries are comparable to those reported in subjects with congestive splenomegaly (Aster, 1966; Harker and Finch, 1969) , and platelet pooling in the spleen appears to be a major factor in the aetiology of the thrombocytopenia in malaria. Splenomegaly with congestion of the red cords is a characteristic feature of malaria and the increased pooling may simply be a reflection of this. However, in thrombocytopenic states due solely to excessive splenic pooling platelet life span is usually normal or near normal (Aster, 1966; Harker and Finch, 1969 Beale et al. (1972) suggested that in malaria immunologically altered platelets are removed at an excessive rate from the blood by the reticuloendothelial system. The results of the present study suggest that this role is a relatively minor one, as the platelet kinetics in the malaria patient do not resemble closely those reported in acute immune thrombocytopenia where platelet recovery is usually normal, platelet life span is reduced to a few hours or less, and platelet turnover is increased from 4 to 9 times (Aster and Jandl, 1964; Harker and Finch, 1969) . By contrast, the malaria patients showed markedly reduced platelet recoveries and only moderate shortening of life span.
No evidence of decreased platelet production in malaria has been found in the present study. Platelet turnover was increased some threefold in five patients and tenfold in one. This moderate increase of platelet turnover in five patients is compatible with splenic pooling (Harker and Finch, 1969 ).
The results of these studies with 51Cr-labelled platelets thus show at least two factors in the mechanism of the thrombocytopenia in malaria, excessive splenic pooling of platelets and decreased platelet life span. The former mechanism is the more important, for the recovery values were extremely low while the decrease in platelet life span was moderate and not as severe as is usually found in patients with acute immune thrombocytopenia.
Thrombocytopenia in severe malaria may be the result of D.I.C. (Dennis et al., 1967; Devakul et al., 1966; Borochovitz et al., 1970) , but D.I.C. is not a feature of uncomplicated malaria (Shulman et al., 1970; Devakul et al., 1966; Jaroonvesama, 1972; Reid and Nkruma, 1972) . In the present study coagulation tests failed to produce evidence of D.I.C. in five of the patients studied. In the sixth patient plasma fibrinogen was moderately decreased, but levels of F.R. antigen were only slightly raised. All was not more rapid than the group as a whole. Thus no supportive evidence has been found that the rapid removal of 5I fibrinogen was associated with D.I.C. Of particular importance is the finding of little or no rise in F.R. antigen levels. Fibrinogen is catabolized directly, without preliminary conversion to fibrin, so that fibrinogen catabolism can be changed without involving coagulation (Regoeczi, 1966) . The site of fibrinogen catabolism is probably the cells of reticuloendothelial system, for experimentally induced hyperendocytosis of the reticuloendothelial system is accompanied by an increased rate of fibrinogen catabolism in rabbits (Regoeczi, 1970) . It is possible that in uncomplicated malaria rapid disappearance from the plasma of injected 12I fibrinogen reflects clearance into the overactive reticuloendothelial system; a mechanism similar to that found with '25I-labelled microaggregated human serum albumin 
Introduction
Early detection of peritoneal infection in the course of dialysis is dearly important. It is well recognized, however, that a positive culture from peritoneal fluid effluent does not invariably indicate significant infection of the peritoneum because contmination of the outflow fluid is common (Frank et al., 1948; Odel et al., 1948) . Such positive cultures do in any case take one or two days before reports are obtained. The presence of polymorphs is taken by some as an index of infection but there is also no doubt that chemical irritation of the peritoneum with glucose enhances the diapedesis of leucocytes (Boen, 1961) . Others rely on naked eye estimation of the turbidity of the fluid due to precipitation of increased protein in cold fluid but in the course of a dialysis protein loss into the peritoneum increases, and the amount of protein lost is greater in patients with glomerulonephritis than pyelonephritis (Bonomini et al., 1967) . This report concems the simple expedient of estimating the lysozyme (muramidase) content of coincident serum and peritoneal fluid samples in order to gauge the onset of peritoneal infection.
Methods
A 5-0-ml sample of clotted blood was taken morning and evening during the course of 'kthree-day peritoneal dialysis (P.D.) on 50 patients, and also peritoneal effluent fluid every sixth cycle. Samples were kept at 4°C before estimation of the lysozyme content by the technique of Harrison et al. (1968) Failure to obtain a positive culture was most certainly due in some cases to the accepted unit policy of treatment with intraperitoneal antibiotics at the first suspicion of infection.
To illustrate the uses of the assay four examples are shown in the figures. A rapid rise of P.D. fluid lysozyme indicative of peritoneal infection and an equally rapid resolution with antibiotic treatment is shown in fig. 1 . A patient's graph whose P.D. fluid lysozyme was 9-10 ,ug/ml but in whom there was only slow response to therapy is shown in fig. 2. Fig. 3 shows the effect on lysozyme levels of infected peritoneal fluid, accompanied by a good response to therapy. The course of a patient with haemorrhagic pancreatitis who showed high but fluctuant levels of P.D. fluid lysozyme together with high serum levels is illustrated in fig. 4 . Clearly, if peritoneal dialysis is used for treatment of pancreatitis a monitor of lysozyme levels can indicate progress.
